, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
measurement categories; amortized cost, fair value through other comprehensive income (“FVOCI”) and profit or loss (“FVTPL”) driven by the entity’s business model for managing its financial instruments and the
and ฿ 88.38 million in comprehensive loss. While total operating in 2018, shows profit and comprehensive earnings at ฿ 19.00 million (same amount). The increasing of administrative expenses is due to
range to accelerate 5G adoption toward the low-mid tier segment corresponding to wider 5G device availability. • The home broadband market showed subsiding demand as the pandemic relaxation created less
three measurement categories; amortized cost, fair value through other comprehensive income (“FVOCI”) and profit or loss (“FVTPL”) driven by the entity’s business model for managing its financial
three measurement categories; amortized cost, fair value through other comprehensive income (“FVOCI”) and profit or loss (“FVTPL”) driven by the entity’s business model for managing its financial
subscribers increased 41% QoQ to stand at 5.5mn from efforts to encourage 5G adoption through affordable 5G packages and device bundling. AIS Fibre continued surging and closed 3Q22 at 2.1mn with net increase
subscribers increased 41% QoQ to stand at 5.5mn from efforts to encourage 5G adoption through affordable 5G packages and device bundling. AIS Fibre continued surging and closed 3Q22 at 2.1mn with net increase
subscribers increased 41% QoQ to stand at 5.5mn from efforts to encourage 5G adoption through affordable 5G packages and device bundling. AIS Fibre continued surging and closed 3Q22 at 2.1mn with net increase